150 related articles for article (PubMed ID: 2095917)
21. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
22. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
23. Transformation effector and suppressor genes.
Boylan MO; Zarbl H
J Cell Biochem; 1991 Jul; 46(3):199-205. PubMed ID: 1774222
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.
Sato KY; Polakis PG; Haubruck H; Fasching CL; McCormick F; Stanbridge EJ
Cancer Res; 1994 Jan; 54(2):552-9. PubMed ID: 8275494
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
26. Mutation in ras proto-oncogenes and malignancy.
Marshall CJ
J UOEH; 1989 Mar; 11 Suppl():398-405. PubMed ID: 2664953
[No Abstract] [Full Text] [Related]
27. Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.
Sircar S; Rodrigues M; Weber JM
Oncogene; 1988 Dec; 3(6):725-8. PubMed ID: 2577877
[TBL] [Abstract][Full Text] [Related]
28. Oncogenes and metastatic progression.
Greenberg AH; Egan SE; Wright JA
Invasion Metastasis; 1989; 9(6):360-78. PubMed ID: 2689384
[TBL] [Abstract][Full Text] [Related]
29. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
Spandidos DA
J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
31. Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line.
Boylan MO; Athanassiou M; Houle B; Wang Y; Zarbl H
Cell Growth Differ; 1996 Jun; 7(6):725-35. PubMed ID: 8780886
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis and secondary expression profiling of candidate genes deregulated in conjunction with oncogenic Ras signaling.
Raudies O; Kuban RJ; Hamacher F; Klein-Hitpass L; Tchernitsa OI; Sers C; Herzel HP; Schäfer R
Adv Enzyme Regul; 2005; 45():63-84. PubMed ID: 16023704
[No Abstract] [Full Text] [Related]
33. Use of revertant cell lines to identify targets of v-fos transformation-specific alterations in gene expression.
Hoemann CD; Zarbl H
Cell Growth Differ; 1990 Dec; 1(12):581-90. PubMed ID: 2126949
[TBL] [Abstract][Full Text] [Related]
34. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.
Subramanian T; La Regina M; Chinnadurai G
Oncogene; 1989 Apr; 4(4):415-20. PubMed ID: 2524023
[TBL] [Abstract][Full Text] [Related]
35. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
Rapp UR; Troppmair J; Beck T; Birrer MJ
Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.
Tchernitsa OI; Zuber J; Sers C; Brinckmann R; Britsch SK; Adams V; Schäfer R
Oncogene; 1999 Sep; 18(39):5448-54. PubMed ID: 10498898
[TBL] [Abstract][Full Text] [Related]
37. The human T24 Ha-ras1 oncogene: a study of the effects of overexpression of the mutated ras gene product in rodent cells.
Spandidos DA
Anticancer Res; 1986; 6(2):259-62. PubMed ID: 3486626
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo onco-suppressor activity of normal cells on cells transformed with the H-ras1 oncogene.
Kakkanas A; Spandidos DA
In Vivo; 1990; 4(2):109-14. PubMed ID: 2129801
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor genes: studies with hybrid mouse cells.
Harris H
Immunol Ser; 1990; 51():1-13. PubMed ID: 2095915
[No Abstract] [Full Text] [Related]
40. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
Subbaramaiah K; Telang N; Ramonetti JT; Araki R; DeVito B; Weksler BB; Dannenberg AJ
Cancer Res; 1996 Oct; 56(19):4424-9. PubMed ID: 8813136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
